268. Nakajo-Nishimura syndrome Clinical trials / Disease details

Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target genes : 2 - Drug target pathways : 35

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04517253 (ClinicalTrials.gov)	October 27, 2020	17/8/2020	A Study of Baricitinib(LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI ...	A Phase 2/3, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Baricitinibin Adul ...	Nakajo-Nishimura Syndrome;Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated T ...	Drug: Baricitinib	Eli Lilly and Company	NULL	Active, not recruiting	6 Months	N/A	All	5	Phase 2/Phase 3	Japan

First Previous1Next Last